Predicting prognosis after stroke: A placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA stroke trial

Michael R. Frankel, L. B. Morgenstern, T. Kwiatkowski, M. Lu, B. C. Tilley, J. P. Broderick, R. Libman, S. R. Levine, Thomas G Brott

Research output: Contribution to journalArticle

185 Citations (Scopus)

Abstract

Background: Physicians are often asked to predict outcome after acute stroke. Very little information is available that can reliably predict the likelihood of severe disability or death. Objective: To develop a practical method for predicting a poor outcome after acute ischemic stroke. Methods: Data from the placebo arms of Parts 1 and 2 of the National Institute of Neurological Disorders and Stroke rt-PA [recombinant tissue plasminogen activator] Stroke Trial were used to identify variables that could predict a poor outcome, defined as moderately severe disability, severe disability, or death (Modified Rankin Scale score >3) 3 months after stroke. Results: Baseline variables that predicted poor outcome were the NIH Stroke Scale (NIHSS) >17 plus atrial fibrillation, yielding a positive predictive value (PPV) of 96% (95% CI, 88 to 100%). The best predictor at 24 hours was NIHSS >22, yielding a PPV of 98% (95% CI, 93 to 100%). The best predictor at 7 to 10 days was NIHSS >16, yielding a PPV of 92% (95% CI, 85 to 99%). Conclusions: Patients with a severe neurologic deficit after acute ischemic stroke, as measured by the NIHSS, have a poor prognosis. During the first week after acute ischemic stroke, it is possible to identify a subset of patients who are highly likely to have a poor outcome. These findings require confirmation in a separate study.

Original languageEnglish (US)
Pages (from-to)952-959
Number of pages8
JournalNeurology
Volume55
Issue number7
StatePublished - Oct 10 2000

Fingerprint

National Institute of Neurological Disorders and Stroke
Tissue Plasminogen Activator
Stroke
Placebos
Neurologic Manifestations
Atrial Fibrillation

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Frankel, M. R., Morgenstern, L. B., Kwiatkowski, T., Lu, M., Tilley, B. C., Broderick, J. P., ... Brott, T. G. (2000). Predicting prognosis after stroke: A placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA stroke trial. Neurology, 55(7), 952-959.

Predicting prognosis after stroke : A placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA stroke trial. / Frankel, Michael R.; Morgenstern, L. B.; Kwiatkowski, T.; Lu, M.; Tilley, B. C.; Broderick, J. P.; Libman, R.; Levine, S. R.; Brott, Thomas G.

In: Neurology, Vol. 55, No. 7, 10.10.2000, p. 952-959.

Research output: Contribution to journalArticle

Frankel, MR, Morgenstern, LB, Kwiatkowski, T, Lu, M, Tilley, BC, Broderick, JP, Libman, R, Levine, SR & Brott, TG 2000, 'Predicting prognosis after stroke: A placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA stroke trial', Neurology, vol. 55, no. 7, pp. 952-959.
Frankel MR, Morgenstern LB, Kwiatkowski T, Lu M, Tilley BC, Broderick JP et al. Predicting prognosis after stroke: A placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA stroke trial. Neurology. 2000 Oct 10;55(7):952-959.
Frankel, Michael R. ; Morgenstern, L. B. ; Kwiatkowski, T. ; Lu, M. ; Tilley, B. C. ; Broderick, J. P. ; Libman, R. ; Levine, S. R. ; Brott, Thomas G. / Predicting prognosis after stroke : A placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA stroke trial. In: Neurology. 2000 ; Vol. 55, No. 7. pp. 952-959.
@article{a8f431d2fe454b4bb3d8deb28a3a2f6c,
title = "Predicting prognosis after stroke: A placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA stroke trial",
abstract = "Background: Physicians are often asked to predict outcome after acute stroke. Very little information is available that can reliably predict the likelihood of severe disability or death. Objective: To develop a practical method for predicting a poor outcome after acute ischemic stroke. Methods: Data from the placebo arms of Parts 1 and 2 of the National Institute of Neurological Disorders and Stroke rt-PA [recombinant tissue plasminogen activator] Stroke Trial were used to identify variables that could predict a poor outcome, defined as moderately severe disability, severe disability, or death (Modified Rankin Scale score >3) 3 months after stroke. Results: Baseline variables that predicted poor outcome were the NIH Stroke Scale (NIHSS) >17 plus atrial fibrillation, yielding a positive predictive value (PPV) of 96{\%} (95{\%} CI, 88 to 100{\%}). The best predictor at 24 hours was NIHSS >22, yielding a PPV of 98{\%} (95{\%} CI, 93 to 100{\%}). The best predictor at 7 to 10 days was NIHSS >16, yielding a PPV of 92{\%} (95{\%} CI, 85 to 99{\%}). Conclusions: Patients with a severe neurologic deficit after acute ischemic stroke, as measured by the NIHSS, have a poor prognosis. During the first week after acute ischemic stroke, it is possible to identify a subset of patients who are highly likely to have a poor outcome. These findings require confirmation in a separate study.",
author = "Frankel, {Michael R.} and Morgenstern, {L. B.} and T. Kwiatkowski and M. Lu and Tilley, {B. C.} and Broderick, {J. P.} and R. Libman and Levine, {S. R.} and Brott, {Thomas G}",
year = "2000",
month = "10",
day = "10",
language = "English (US)",
volume = "55",
pages = "952--959",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Predicting prognosis after stroke

T2 - A placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA stroke trial

AU - Frankel, Michael R.

AU - Morgenstern, L. B.

AU - Kwiatkowski, T.

AU - Lu, M.

AU - Tilley, B. C.

AU - Broderick, J. P.

AU - Libman, R.

AU - Levine, S. R.

AU - Brott, Thomas G

PY - 2000/10/10

Y1 - 2000/10/10

N2 - Background: Physicians are often asked to predict outcome after acute stroke. Very little information is available that can reliably predict the likelihood of severe disability or death. Objective: To develop a practical method for predicting a poor outcome after acute ischemic stroke. Methods: Data from the placebo arms of Parts 1 and 2 of the National Institute of Neurological Disorders and Stroke rt-PA [recombinant tissue plasminogen activator] Stroke Trial were used to identify variables that could predict a poor outcome, defined as moderately severe disability, severe disability, or death (Modified Rankin Scale score >3) 3 months after stroke. Results: Baseline variables that predicted poor outcome were the NIH Stroke Scale (NIHSS) >17 plus atrial fibrillation, yielding a positive predictive value (PPV) of 96% (95% CI, 88 to 100%). The best predictor at 24 hours was NIHSS >22, yielding a PPV of 98% (95% CI, 93 to 100%). The best predictor at 7 to 10 days was NIHSS >16, yielding a PPV of 92% (95% CI, 85 to 99%). Conclusions: Patients with a severe neurologic deficit after acute ischemic stroke, as measured by the NIHSS, have a poor prognosis. During the first week after acute ischemic stroke, it is possible to identify a subset of patients who are highly likely to have a poor outcome. These findings require confirmation in a separate study.

AB - Background: Physicians are often asked to predict outcome after acute stroke. Very little information is available that can reliably predict the likelihood of severe disability or death. Objective: To develop a practical method for predicting a poor outcome after acute ischemic stroke. Methods: Data from the placebo arms of Parts 1 and 2 of the National Institute of Neurological Disorders and Stroke rt-PA [recombinant tissue plasminogen activator] Stroke Trial were used to identify variables that could predict a poor outcome, defined as moderately severe disability, severe disability, or death (Modified Rankin Scale score >3) 3 months after stroke. Results: Baseline variables that predicted poor outcome were the NIH Stroke Scale (NIHSS) >17 plus atrial fibrillation, yielding a positive predictive value (PPV) of 96% (95% CI, 88 to 100%). The best predictor at 24 hours was NIHSS >22, yielding a PPV of 98% (95% CI, 93 to 100%). The best predictor at 7 to 10 days was NIHSS >16, yielding a PPV of 92% (95% CI, 85 to 99%). Conclusions: Patients with a severe neurologic deficit after acute ischemic stroke, as measured by the NIHSS, have a poor prognosis. During the first week after acute ischemic stroke, it is possible to identify a subset of patients who are highly likely to have a poor outcome. These findings require confirmation in a separate study.

UR - http://www.scopus.com/inward/record.url?scp=0034633789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034633789&partnerID=8YFLogxK

M3 - Article

C2 - 11061250

AN - SCOPUS:0034633789

VL - 55

SP - 952

EP - 959

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 7

ER -